This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange added 6.1 points to 1,010.98 Wednesday. Scott Hayduk's NEX shell, Tilting Capital Corp. (TLL), is the latest shell to arrange a deal with a medical marijuana company. It plans to acquire MMJ Bioscience Inc., a hopeful grower with a laboratory in Duncan, B.C., for an unstated number of shares.

Tilting's target does not yet have a licence from Health Canada to produce medical marijuana, but in January the government sent a letter to MMJ Bioscience stating it would visit for a prelicence inspection after the company installed a vault, a cage and an electronic security system at its facilities in Duncan. Three months have passed and the government has still not inspected, but MMJ Bioscience says that it anticipates getting the production licence before it goes public. Securing the licence is also probably a condition of Canaccord Genuity Corp., which has agreed to sponsor the deal and handle a private placement after it completes due diligence.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS